top of page
Mountians and Lake

welcome to


Data Driven Individualized Treatments for every patient
Pathway towards cure


MCT is a Myeloma Education Website to provide a seamless source of information for Myeloma community around the world. 

perseus nejm dara rvd.JPG

NCT03710603 - A Phase 3 Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) vs VELCADE, Lenalidomide, and Dexamethasone (VRd) in  Previously Untreated Multiple Myeloma Who Are Eligible for High-dose Therapy (Perseus)

N Engl J Med - Publication - January 25, 2024

bottom of page